| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 36 | 2021 | 199 | 3.730 |
Why?
|
| Anastomotic Leak | 17 | 2023 | 109 | 1.750 |
Why?
|
| Pseudomonas Infections | 16 | 2019 | 94 | 1.540 |
Why?
|
| Intestinal Mucosa | 21 | 2017 | 825 | 1.240 |
Why?
|
| Enterococcus faecalis | 12 | 2022 | 57 | 1.140 |
Why?
|
| Sepsis | 17 | 2025 | 382 | 1.080 |
Why?
|
| Surgical Wound Infection | 7 | 2022 | 236 | 0.810 |
Why?
|
| Intestines | 14 | 2020 | 433 | 0.800 |
Why?
|
| Phosphates | 12 | 2022 | 161 | 0.800 |
Why?
|
| Diet, Western | 6 | 2025 | 45 | 0.760 |
Why?
|
| Gastrointestinal Microbiome | 10 | 2025 | 595 | 0.750 |
Why?
|
| Polyethylene Glycols | 10 | 2020 | 371 | 0.730 |
Why?
|
| Macrophages | 12 | 2025 | 609 | 0.690 |
Why?
|
| Virulence | 23 | 2020 | 273 | 0.690 |
Why?
|
| Bacterial Proteins | 10 | 2020 | 878 | 0.610 |
Why?
|
| Colon | 8 | 2021 | 540 | 0.590 |
Why?
|
| Mice | 47 | 2025 | 12224 | 0.570 |
Why?
|
| Collagenases | 7 | 2022 | 42 | 0.570 |
Why?
|
| Anastomosis, Surgical | 12 | 2023 | 280 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 27 | 2025 | 3430 | 0.570 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2013 | 51 | 0.520 |
Why?
|
| Animals | 64 | 2025 | 27965 | 0.520 |
Why?
|
| Wound Healing | 6 | 2019 | 372 | 0.490 |
Why?
|
| Receptors, Purinergic P2 | 4 | 2000 | 16 | 0.470 |
Why?
|
| Stress, Physiological | 5 | 2011 | 245 | 0.460 |
Why?
|
| Anti-Bacterial Agents | 10 | 2025 | 833 | 0.430 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2014 | 10 | 0.430 |
Why?
|
| Cell Membrane Structures | 1 | 2014 | 3 | 0.410 |
Why?
|
| Cell Surface Extensions | 1 | 2014 | 11 | 0.410 |
Why?
|
| Colectomy | 3 | 2019 | 192 | 0.400 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 429 | 0.390 |
Why?
|
| Disease Models, Animal | 15 | 2025 | 2479 | 0.380 |
Why?
|
| Gastrointestinal Tract | 5 | 2020 | 196 | 0.380 |
Why?
|
| Bacteria | 4 | 2025 | 508 | 0.380 |
Why?
|
| Caenorhabditis elegans | 10 | 2016 | 245 | 0.380 |
Why?
|
| Colorectal Surgery | 2 | 2023 | 22 | 0.360 |
Why?
|
| Plasminogen | 2 | 2021 | 45 | 0.320 |
Why?
|
| Adhesins, Bacterial | 6 | 2012 | 36 | 0.320 |
Why?
|
| Lectins | 6 | 2012 | 82 | 0.320 |
Why?
|
| Microbiota | 4 | 2016 | 431 | 0.310 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2025 | 81 | 0.300 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2011 | 204 | 0.300 |
Why?
|
| Adenosine Triphosphate | 6 | 2007 | 312 | 0.300 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2020 | 83 | 0.300 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2021 | 133 | 0.300 |
Why?
|
| Cecum | 6 | 2025 | 78 | 0.280 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 1054 | 0.280 |
Why?
|
| Quorum Sensing | 2 | 2013 | 28 | 0.270 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2008 | 24 | 0.270 |
Why?
|
| Quinolones | 2 | 2012 | 57 | 0.270 |
Why?
|
| Intestinal Diseases | 3 | 2016 | 84 | 0.270 |
Why?
|
| Hydrogels | 2 | 2020 | 92 | 0.270 |
Why?
|
| Polyphosphates | 2 | 2018 | 8 | 0.260 |
Why?
|
| Nucleoside-Diphosphate Kinase | 4 | 2007 | 12 | 0.260 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.260 |
Why?
|
| Hydroquinones | 2 | 1998 | 7 | 0.250 |
Why?
|
| Apoptosis | 9 | 2016 | 1719 | 0.240 |
Why?
|
| Fecal Microbiota Transplantation | 3 | 2025 | 80 | 0.240 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2021 | 260 | 0.240 |
Why?
|
| Serratia marcescens | 3 | 2025 | 12 | 0.230 |
Why?
|
| Burkholderia cepacia | 3 | 2003 | 3 | 0.230 |
Why?
|
| Pyocyanine | 4 | 2016 | 12 | 0.220 |
Why?
|
| Serratia Infections | 1 | 2025 | 6 | 0.220 |
Why?
|
| Enterobactin | 1 | 2025 | 8 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 10 | 2023 | 1099 | 0.220 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 26 | 0.220 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2552 | 0.210 |
Why?
|
| Analgesics, Opioid | 3 | 2016 | 515 | 0.210 |
Why?
|
| Critical Illness | 4 | 2014 | 342 | 0.210 |
Why?
|
| Epithelial Cells | 5 | 2017 | 700 | 0.210 |
Why?
|
| Tranexamic Acid | 2 | 2021 | 43 | 0.200 |
Why?
|
| Humans | 46 | 2023 | 93138 | 0.200 |
Why?
|
| Peptide YY | 1 | 2023 | 9 | 0.200 |
Why?
|
| Paneth Cells | 1 | 2023 | 10 | 0.200 |
Why?
|
| Collagen | 4 | 2021 | 301 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2020 | 3497 | 0.200 |
Why?
|
| Candida | 1 | 2023 | 20 | 0.200 |
Why?
|
| Morphine | 2 | 2016 | 127 | 0.200 |
Why?
|
| Butyrates | 2 | 2020 | 56 | 0.200 |
Why?
|
| Virulence Factors | 4 | 2017 | 113 | 0.190 |
Why?
|
| Bacterial Adhesion | 5 | 2013 | 83 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 3 | 2019 | 240 | 0.190 |
Why?
|
| Antifungal Agents | 1 | 2023 | 122 | 0.190 |
Why?
|
| Infection Control | 2 | 2017 | 130 | 0.190 |
Why?
|
| Azurin | 4 | 2003 | 5 | 0.190 |
Why?
|
| Iron | 4 | 2017 | 173 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 3 | 2000 | 140 | 0.180 |
Why?
|
| Biofilms | 4 | 2018 | 50 | 0.180 |
Why?
|
| Drinking Water | 1 | 2022 | 70 | 0.170 |
Why?
|
| Peptide Fragments | 1 | 2023 | 468 | 0.170 |
Why?
|
| Caspases | 2 | 2003 | 151 | 0.170 |
Why?
|
| Maleates | 2 | 1998 | 3 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2019 | 83 | 0.170 |
Why?
|
| Pancreatitis | 1 | 2021 | 94 | 0.160 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2020 | 18 | 0.160 |
Why?
|
| Intestine, Small | 2 | 2013 | 311 | 0.160 |
Why?
|
| Clonidine | 1 | 2020 | 33 | 0.160 |
Why?
|
| Propranolol | 1 | 2020 | 42 | 0.160 |
Why?
|
| Caco-2 Cells | 7 | 2011 | 125 | 0.160 |
Why?
|
| Peptide Hydrolases | 1 | 2020 | 99 | 0.150 |
Why?
|
| Diet, Fat-Restricted | 1 | 2019 | 30 | 0.150 |
Why?
|
| Rectal Neoplasms | 1 | 2021 | 132 | 0.150 |
Why?
|
| Collagen Type IV | 1 | 2019 | 28 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2019 | 46 | 0.150 |
Why?
|
| Cystic Fibrosis | 2 | 2003 | 119 | 0.150 |
Why?
|
| Preoperative Care | 2 | 2019 | 404 | 0.150 |
Why?
|
| Bacillus subtilis | 1 | 2020 | 89 | 0.150 |
Why?
|
| Male | 22 | 2025 | 44357 | 0.150 |
Why?
|
| Fibrinolysis | 1 | 2019 | 35 | 0.150 |
Why?
|
| Acinetobacter baumannii | 2 | 2017 | 27 | 0.150 |
Why?
|
| Collagen Type I | 1 | 2019 | 74 | 0.150 |
Why?
|
| Immune System | 1 | 2020 | 101 | 0.150 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 52 | 0.150 |
Why?
|
| Fimbriae Proteins | 1 | 1999 | 15 | 0.150 |
Why?
|
| Mycobacterium bovis | 1 | 1999 | 16 | 0.150 |
Why?
|
| Colonic Diseases | 1 | 2019 | 59 | 0.150 |
Why?
|
| Immunity | 1 | 2020 | 153 | 0.140 |
Why?
|
| Hepatectomy | 4 | 2018 | 177 | 0.140 |
Why?
|
| Lyases | 1 | 1998 | 11 | 0.140 |
Why?
|
| Candida albicans | 3 | 2014 | 32 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 250 | 0.140 |
Why?
|
| Phenotype | 8 | 2022 | 2545 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 256 | 0.140 |
Why?
|
| Cell Line | 9 | 2017 | 2458 | 0.140 |
Why?
|
| Oligopeptides | 2 | 2016 | 190 | 0.130 |
Why?
|
| Cell Membrane Permeability | 3 | 2013 | 121 | 0.130 |
Why?
|
| Phenols | 2 | 2015 | 41 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 2022 | 578 | 0.130 |
Why?
|
| Wound Infection | 1 | 2017 | 17 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 85 | 0.130 |
Why?
|
| Acinetobacter Infections | 1 | 2017 | 17 | 0.130 |
Why?
|
| Polymers | 2 | 2022 | 217 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 3 | 2000 | 9 | 0.120 |
Why?
|
| Operating Rooms | 1 | 2017 | 137 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 191 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 284 | 0.110 |
Why?
|
| Fascia | 1 | 2015 | 32 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 638 | 0.110 |
Why?
|
| Streptomyces | 1 | 1995 | 20 | 0.110 |
Why?
|
| Oxygenases | 1 | 1995 | 17 | 0.110 |
Why?
|
| Mutation | 4 | 2016 | 4265 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 156 | 0.110 |
Why?
|
| Opportunistic Infections | 2 | 2012 | 57 | 0.110 |
Why?
|
| Rats, Wistar | 4 | 2016 | 300 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 191 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 198 | 0.110 |
Why?
|
| Thiazoles | 1 | 2015 | 124 | 0.110 |
Why?
|
| Dioxygenases | 1 | 1995 | 82 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 121 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1049 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1908 | 0.100 |
Why?
|
| Negative Staining | 1 | 2014 | 2 | 0.100 |
Why?
|
| Computer Simulation | 3 | 2013 | 1119 | 0.100 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2014 | 28 | 0.100 |
Why?
|
| Cytostatic Agents | 1 | 2013 | 4 | 0.100 |
Why?
|
| Rats | 6 | 2020 | 4028 | 0.100 |
Why?
|
| Nicotine | 1 | 2016 | 208 | 0.100 |
Why?
|
| Models, Animal | 4 | 2019 | 280 | 0.100 |
Why?
|
| Candidiasis | 1 | 2013 | 39 | 0.100 |
Why?
|
| Random Allocation | 4 | 2018 | 308 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 409 | 0.100 |
Why?
|
| Obesity | 1 | 2019 | 1014 | 0.090 |
Why?
|
| Ileum | 2 | 2012 | 167 | 0.090 |
Why?
|
| Base Sequence | 3 | 2012 | 2207 | 0.090 |
Why?
|
| Peritonitis | 1 | 2012 | 28 | 0.090 |
Why?
|
| Protein Transport | 1 | 2014 | 437 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 178 | 0.090 |
Why?
|
| Oxidants | 1 | 2012 | 86 | 0.090 |
Why?
|
| DNA Primers | 2 | 2006 | 528 | 0.090 |
Why?
|
| Organ Preservation | 1 | 2013 | 130 | 0.090 |
Why?
|
| Mast Cells | 3 | 2000 | 96 | 0.090 |
Why?
|
| Feces | 4 | 2020 | 360 | 0.090 |
Why?
|
| Siderophores | 1 | 2011 | 21 | 0.090 |
Why?
|
| Hypoxia | 1 | 2016 | 672 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 81 | 0.080 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 77 | 0.080 |
Why?
|
| Cells, Cultured | 6 | 2013 | 2827 | 0.080 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2022 | 49 | 0.080 |
Why?
|
| Necrosis | 3 | 2012 | 203 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 148 | 0.080 |
Why?
|
| Drug Design | 1 | 2011 | 133 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 346 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2012 | 504 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2002 | 453 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2009 | 41 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 52 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 281 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 98 | 0.070 |
Why?
|
| Ischemia | 3 | 2018 | 252 | 0.070 |
Why?
|
| Molecular Weight | 4 | 2013 | 279 | 0.070 |
Why?
|
| Models, Biological | 2 | 2013 | 1768 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2020 | 276 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 2 | 2008 | 217 | 0.070 |
Why?
|
| Leishmania | 1 | 2007 | 7 | 0.070 |
Why?
|
| Longevity | 1 | 2008 | 60 | 0.070 |
Why?
|
| Biomarkers | 3 | 2021 | 1905 | 0.070 |
Why?
|
| Rectus Abdominis | 2 | 2018 | 41 | 0.060 |
Why?
|
| Software | 1 | 2011 | 669 | 0.060 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 10 | 0.060 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 981 | 0.060 |
Why?
|
| Adenylate Kinase | 3 | 2001 | 14 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 232 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 2889 | 0.060 |
Why?
|
| Cell Death | 4 | 2001 | 252 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2011 | 161 | 0.060 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 17 | 0.060 |
Why?
|
| Gentamicins | 1 | 2006 | 20 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Bacterial Translocation | 3 | 2013 | 26 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1529 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 477 | 0.060 |
Why?
|
| Actins | 1 | 2008 | 467 | 0.060 |
Why?
|
| Porins | 1 | 2005 | 24 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2013 | 1518 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 170 | 0.060 |
Why?
|
| Endotoxins | 1 | 2005 | 36 | 0.050 |
Why?
|
| Intensive Care Units | 3 | 2016 | 450 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 1994 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 2020 | 142 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2007 | 69 | 0.050 |
Why?
|
| Tryptophan | 1 | 2025 | 104 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2485 | 0.050 |
Why?
|
| Water | 1 | 2006 | 306 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2000 | 302 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 888 | 0.050 |
Why?
|
| Movement | 1 | 2006 | 307 | 0.050 |
Why?
|
| Cell Survival | 1 | 2006 | 1002 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 57 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2005 | 459 | 0.050 |
Why?
|
| Adenosine | 1 | 2006 | 274 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2006 | 2757 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2018 | 655 | 0.050 |
Why?
|
| Adenosine Diphosphate | 2 | 2000 | 58 | 0.050 |
Why?
|
| Symbiosis | 1 | 2023 | 128 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1359 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 1114 | 0.040 |
Why?
|
| Zonula Occludens-1 Protein | 2 | 2012 | 70 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 577 | 0.040 |
Why?
|
| Enema | 1 | 2021 | 35 | 0.040 |
Why?
|
| Taurocholic Acid | 1 | 2021 | 6 | 0.040 |
Why?
|
| Critical Care | 1 | 2005 | 442 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2021 | 281 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 73 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2003 | 299 | 0.040 |
Why?
|
| Cytochrome-c Peroxidase | 1 | 2000 | 2 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2000 | 25 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 35 | 0.040 |
Why?
|
| Vibrio cholerae | 1 | 2000 | 18 | 0.040 |
Why?
|
| Phagocytes | 1 | 2000 | 15 | 0.040 |
Why?
|
| Burkholderia Infections | 1 | 2000 | 2 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 3169 | 0.040 |
Why?
|
| Proteomics | 2 | 2014 | 261 | 0.040 |
Why?
|
| Butyric Acid | 1 | 2020 | 12 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 16 | 0.040 |
Why?
|
| Enzymes | 1 | 2000 | 47 | 0.040 |
Why?
|
| Protective Factors | 1 | 2019 | 28 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 126 | 0.040 |
Why?
|
| Mice, Inbred AKR | 1 | 1999 | 9 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 109 | 0.040 |
Why?
|
| Caseins | 1 | 1999 | 9 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2121 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2020 | 71 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 125 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 875 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2019 | 36 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 402 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 1999 | 83 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 121 | 0.040 |
Why?
|
| Time Factors | 3 | 2009 | 5379 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 107 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 555 | 0.040 |
Why?
|
| Infliximab | 1 | 2020 | 162 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 44 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 47 | 0.040 |
Why?
|
| Proteolysis | 1 | 2019 | 124 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 1517 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 284 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 435 | 0.040 |
Why?
|
| Cytochrome c Group | 3 | 2003 | 82 | 0.040 |
Why?
|
| Colorimetry | 1 | 1998 | 8 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1276 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 1999 | 80 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 204 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 5901 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2020 | 202 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2011 | 479 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 1998 | 187 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 199 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2017 | 6 | 0.030 |
Why?
|
| Abscess | 1 | 2018 | 94 | 0.030 |
Why?
|
| Gelatinases | 1 | 2017 | 10 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2020 | 494 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 40 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 235 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 364 | 0.030 |
Why?
|
| Culture Media | 1 | 2017 | 138 | 0.030 |
Why?
|
| Endoscopy | 1 | 2021 | 366 | 0.030 |
Why?
|
| Cell Shape | 1 | 2017 | 50 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 1051 | 0.030 |
Why?
|
| Myocardium | 1 | 2020 | 567 | 0.030 |
Why?
|
| Moths | 1 | 2017 | 32 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 148 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 2017 | 47 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1447 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Neutrophils | 1 | 2018 | 324 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 916 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1188 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1160 | 0.030 |
Why?
|
| Electric Impedance | 2 | 2008 | 115 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 10132 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 774 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 119 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 163 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cytokines | 2 | 2012 | 862 | 0.030 |
Why?
|
| Chlorophenols | 1 | 1995 | 1 | 0.030 |
Why?
|
| Azotobacter | 1 | 1995 | 3 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 95 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 24 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2006 | 275 | 0.030 |
Why?
|
| Metalloproteins | 1 | 1995 | 16 | 0.030 |
Why?
|
| ras Proteins | 1 | 2016 | 132 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 1995 | 18 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cell Hypoxia | 2 | 2006 | 186 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Enterobacteriaceae | 1 | 2014 | 22 | 0.030 |
Why?
|
| Cathartics | 1 | 2014 | 27 | 0.030 |
Why?
|
| Locomotion | 1 | 2016 | 144 | 0.030 |
Why?
|
| Enterococcus | 1 | 2014 | 34 | 0.030 |
Why?
|
| Homeostasis | 1 | 2016 | 459 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2016 | 199 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 361 | 0.030 |
Why?
|
| Metagenomics | 1 | 2014 | 101 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 9074 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 83 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 103 | 0.020 |
Why?
|
| Cold Ischemia | 1 | 2013 | 22 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2013 | 35 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2013 | 70 | 0.020 |
Why?
|
| Radiation | 1 | 2012 | 16 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 32 | 0.020 |
Why?
|
| Chloramines | 1 | 2012 | 20 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 13 | 0.020 |
Why?
|
| Lactobacillus | 1 | 2012 | 23 | 0.020 |
Why?
|
| Calibration | 1 | 2012 | 107 | 0.020 |
Why?
|
| Protective Agents | 1 | 2012 | 34 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 85 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 28 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 314 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1995 | 907 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 137 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 13 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 2301 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2003 | 410 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 74 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2011 | 46 | 0.020 |
Why?
|
| Tight Junctions | 1 | 2012 | 154 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 941 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 145 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 355 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 296 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 255 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 603 | 0.020 |
Why?
|
| Microclimate | 1 | 2010 | 4 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 258 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 885 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1055 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 386 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2008 | 36 | 0.020 |
Why?
|
| Color | 1 | 2009 | 80 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 121 | 0.020 |
Why?
|
| Thrombin | 1 | 2008 | 60 | 0.020 |
Why?
|
| Cues | 1 | 2010 | 186 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2008 | 34 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 891 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1980 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2008 | 68 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2008 | 138 | 0.020 |
Why?
|
| Cholesterol | 1 | 2009 | 364 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 72 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2008 | 198 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1236 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 18 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1732 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1611 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 273 | 0.010 |
Why?
|
| Stomach | 1 | 2006 | 110 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1260 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 177 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2005 | 64 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 877 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 273 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 848 | 0.010 |
Why?
|
| Toxicity Tests | 1 | 2003 | 12 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 32 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 52 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 79 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2002 | 64 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 83 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 727 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 54 | 0.010 |
Why?
|
| Female | 3 | 2019 | 48544 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 798 | 0.010 |
Why?
|
| Cytosol | 1 | 2002 | 192 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2002 | 112 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 1526 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 203 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 2001 | 57 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 1093 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1022 | 0.010 |
Why?
|
| Catalysis | 1 | 2001 | 215 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2002 | 823 | 0.010 |
Why?
|
| 5'-Nucleotidase | 1 | 2000 | 14 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 790 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 27850 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2000 | 43 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 2000 | 29 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 601 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 502 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 562 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 550 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 663 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 612 | 0.010 |
Why?
|
| Environment | 1 | 2000 | 230 | 0.010 |
Why?
|
| Melanoma | 1 | 2002 | 494 | 0.010 |
Why?
|